Correction : Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives
| Errataetall: |
ErratumFor: Naunyn Schmiedebergs Arch Pharmacol. 2023 Feb;396(2):191-212. - PMID 36214865 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Naunyn-Schmiedeberg's archives of pharmacology - (2024) vom: 15. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tuli, Hardeep Singh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 15.04.2024 published: Print-Electronic ErratumFor: Naunyn Schmiedebergs Arch Pharmacol. 2023 Feb;396(2):191-212. - PMID 36214865 Citation Status Publisher |
|---|
| doi: |
10.1007/s00210-024-03083-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371089204 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371089204 | ||
| 003 | DE-627 | ||
| 005 | 20240415234834.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00210-024-03083-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM371089204 | ||
| 035 | |a (NLM)38619590 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tuli, Hardeep Singh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction |b Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Naunyn Schmiedebergs Arch Pharmacol. 2023 Feb;396(2):191-212. - PMID 36214865 | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Garg, Vivek Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Ajay |e verfasserin |4 aut | |
| 700 | 1 | |a Aggarwal, Diwakar |e verfasserin |4 aut | |
| 700 | 1 | |a Anand, Uttpal |e verfasserin |4 aut | |
| 700 | 1 | |a Parashar, Nidarshana Chaturvedi |e verfasserin |4 aut | |
| 700 | 1 | |a Saini, Adesh K |e verfasserin |4 aut | |
| 700 | 1 | |a Mohapatra, Ranjan K |e verfasserin |4 aut | |
| 700 | 1 | |a Dhama, Kuldeep |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Manoj |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Tejveer |e verfasserin |4 aut | |
| 700 | 1 | |a Kaur, Jagjit |e verfasserin |4 aut | |
| 700 | 1 | |a Sak, Katrin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Naunyn-Schmiedeberg's archives of pharmacology |d 1972 |g (2024) vom: 15. Apr. |w (DE-627)NLM000008354 |x 1432-1912 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:15 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00210-024-03083-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 15 |c 04 | ||